David P. Upjohn

Papers

Total Citations

H-Index

About

David P. Upjohn is a pioneering researcher at the intersection of pharmacogenomics and orthopedic surgery, with a focused interest in personalized pain management for joint replacement patients. His most notable work, a 2023 randomized trial published in a leading journal, investigates whether preoperative pharmacogenomic testing can improve postoperative pain control in patients undergoing total knee arthroplasty (TKA). This study, which has already garnered 7 citations in a short time, addresses the critical challenge of interindividual variability in analgesic efficacy and adverse drug events—a major barrier to successful pain management. Upjohn’s research demonstrates that affordable, preemptive genetic testing can tailor pain regimens to individual patients, potentially reducing opioid dependence and enhancing recovery outcomes. By bridging genomics and clinical practice, his work offers a transformative approach to perioperative care, positioning him as a key figure in the emerging field of precision medicine for surgical populations. His contributions are particularly relevant for students and researchers interested in how genetic insights can optimize treatment protocols and improve patient quality of life.